Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
1.070
-0.050 (-4.46%)
At close: Feb 21, 2025, 4:00 PM
1.090
+0.020 (1.87%)
After-hours: Feb 21, 2025, 7:52 PM EST
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $223.25 million as of February 21, 2025. Its market cap has increased by 141.61% in one year.
Market Cap
223.25M
Enterprise Value
211.78M
1-Year Change
141.61%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $223.25M, a decrease of -28.92%. That is a compound annual growth rate of -1.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 223.30M | 4.93% |
| Dec 31, 2024 | 212.80M | 120.98% |
| Dec 29, 2023 | 96.30M | -81.29% |
| Dec 30, 2022 | 514.60M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | 2.21B | 127.45% |
| Dec 31, 2019 | 970.40M | -17.20% |
| Dec 31, 2018 | 1.17B | -15.45% |
| Dec 29, 2017 | 1.39B | 543.50% |
| Dec 30, 2016 | 215.40M | -66.32% |
| Dec 31, 2015 | 639.50M | -38.53% |
| Dec 31, 2014 | 1.04B | 21.20% |
| Dec 31, 2013 | 858.40M | 169.51% |
| Dec 31, 2012 | 318.50M | 113.76% |
| Dec 30, 2011 | 149.00M | -50.38% |
| Dec 31, 2010 | 300.30M | 12.98% |
| Dec 31, 2009 | 265.80M | 86.40% |
| Dec 31, 2008 | 142.60M | -72.71% |
| Dec 31, 2007 | 522.60M | 133.30% |
| Dec 29, 2006 | 224.00M | 118.75% |
| Dec 30, 2005 | 102.40M | -32.23% |
| Dec 31, 2004 | 151.10M | 11.35% |
| Dec 31, 2003 | 135.70M | 83.13% |
| Dec 31, 2002 | 74.10M | -67.54% |
| Dec 31, 2001 | 228.30M | -47.02% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 797.70B |
| UnitedHealth Group | 420.35B |
| Johnson & Johnson | 389.50B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.11B |
| Abbott Laboratories | 234.18B |
| AstraZeneca | 227.07B |
| Merck & Co. | 225.26B |